Inactive Instrument
BSF Enterprise Plc Stock OTC Markets
Stocks
BSFA.F
GB00BHNBDQ51
Pharmaceuticals
OTC Markets Traded| Market Cap | 2.16M 2.86M 2.55M 2.37M 4.06M 271M 4.13M 28.5M 11.15M 141M 10.73M 10.51M 452M | P/E 2024 |
-2.47x | P/E 2025 | -3.56x |
|---|---|---|---|---|---|
| Enterprise Value | 2.01M 2.66M 2.38M 2.21M 3.78M 252M 3.85M 26.53M 10.38M 132M 9.99M 9.78M 421M | EV / Sales 2024 |
61,809,222x | EV / Sales 2025 | 76,138,323x |
| Free-Float |
81.3% | Yield 2024 * |
-
| Yield 2025 | - |
| 02-06 | BSF : Proxy Form | PU |
| 02-06 | BSF : Notice of AGM | PU |
| 25-03-06 | BSF : Publication of Prospectus | PU |
| 25-03-06 | BSF : Prospectus | PU |
| 25-02-07 | BSF : Proxy Form | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Che Connon
CEO | Chief Executive Officer | 54 | - |
Graham Duncan
DFI | Director of Finance/CFO | 62 | 2022-06-05 |
Ricardo Gouveia
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Geoffrey Baker
CHM | Chairman | 70 | 2025-12-04 |
Kian Jing Ow
BRD | Director/Board Member | 60 | 2021-08-04 |
Che Connon
BRD | Director/Board Member | 54 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.78M | |
| +3.55% | +7.01% | +51.42% | +105.45% | 1,077B | |
| -0.25% | -1.25% | +32.49% | +61.48% | 612B | |
| +0.59% | +4.03% | +25.28% | +91.54% | 501B | |
| -1.48% | +1.97% | +72.62% | +39.59% | 364B | |
| +2.37% | +7.66% | +33.65% | +48.87% | 353B | |
| +2.64% | +6.95% | +21.01% | +43.85% | 278B | |
| +3.24% | +6.78% | +0.43% | +15.71% | 251B | |
| +1.86% | +6.53% | +45.98% | +52.77% | 230B | |
| +2.49% | +6.98% | +33.03% | +102.67% | 190B | |
| Average | +1.50% | +4.22% | +35.10% | +62.44% | 428.5B | |
| Weighted average by Cap. | +1.74% | +4.12% | +38.65% | +71.72% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.06 0.08 0.07 0.06 0.11 7.26 0.11 0.76 0.3 3.79 0.29 0.28 12.12 | 0.05 0.07 0.06 0.06 0.1 6.63 0.1 0.7 0.27 3.46 0.26 0.26 11.07 |
| Net income | -1.67M -2.22M -1.98M -1.84M -3.15M -210M -3.2M -22.08M -8.64M -110M -8.32M -8.14M -350M | -1.11M -1.48M -1.32M -1.22M -2.09M -140M -2.13M -14.7M -5.75M -72.92M -5.54M -5.42M -233M |
| Net Debt | -560K -742K -662K -615K -1.05M -70.24M -1.07M -7.39M -2.89M -36.65M -2.78M -2.72M -117M | -149K -197K -176K -164K -280K -18.7M -285K -1.97M -770K -9.76M -741K -725K -31.23M |
Employees
14
Sector
Pharmaceuticals
